SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page24252627282930Next Page
2026-04-03CASI3CASI Pharmaceuticals COO Chunhua Wang's Stock Option Holdings Disclosure
This SEC Form 3 filing discloses the initial beneficial ownership of stock options by Chunhua Wang, Chief Operating Officer of CASI Pharmaceuticals, Inc. The filing reports Wang's holdings of 14 stock option grants with varying expiration dates from 2028 to 2034. The options cover a total of 200,000 ordinary shares wit...
Nano CapBiotechnology
Previous Page24252627282930Next Page